SCHEMBL9116579

SCHEMBL9116579

CCC1C=c2cc3c(c(C)c2N1C(=O)OC)=C(C)C(C(=O)O)=N3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966091 0.62
SCHEMBL9562196 0.48 P2RX4 (0.44)
Propionic Acid SCHEMBL28919819 0.46 ALDH1A1 (0.43)
SCHEMBL14825913 0.45 LPO (0.44)
SCHEMBL11603709 0.45 TSHR (0.41)
SCHEMBL27876489 0.44 ALDH1A1 (0.46)
SCHEMBL11056444 0.43 KMT2A (0.46)
SCHEMBL3630207 0.42 P2RX4 (0.48)
SCHEMBL320438 0.42 P2RX4 (0.48)
SCHEMBL3654048 0.42 MYC (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995021171-A1 TRICYCLIC DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 1995-08-10 WO disclosed